La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Mesh.i » - entrée « Survival Analysis »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Surveys and Questionnaires < Survival Analysis < Survival Rate  Facettes :

List of bibliographic references indexed by Survival Analysis

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
002065 (2009) R. B. Postuma [Canada] ; J. F. Gagnon [Canada] ; M. Vendette [Canada] ; M. L. Fantini [Italie] ; J. Massicotte-Marquez [Canada] ; J. Montplaisir [Canada]Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder
002137 (2008) Ian G. Stiell ; Lisa P. Nesbitt ; William Pickett ; Douglas Munkley ; Daniel W. Spaite ; Jane Banek ; Brian Field ; Lorraine Luinstra-Toohey ; Justin Maloney ; Jon Dreyer ; Marion Lyver ; Tony Campeau ; George A. WellsThe OPALS Major Trauma Study: impact of advanced life-support on survival and morbidity.
002753 (2006) Peter A. Biro [Canada] ; Mark V. Abrahams ; John R. Post ; Eric A. ParkinsonBehavioural trade-offs between growth and mortality explain evolution of submaximal growth rates.
002956 (2005) C. Marras [Canada] ; M P Mcdermott ; P A Rochon ; C M Tanner ; G. Naglie ; A. Rudolph ; A E LangSurvival in Parkinson disease: thirteen-year follow-up of the DATATOP cohort.
002D84 (2003) David A. Ashburn [Canada] ; Louise Harris ; Eugene H. Downar ; Sam Siu ; Gary D. Webb ; William G. WilliamsElectrophysiologic surgery in patients with congenital heart disease.
003111 (2001) M. Guttman [Canada] ; P M Slaughter ; M E Theriault ; D P Deboer ; C D NaylorParkinsonism in Ontario: increased mortality compared with controls in a large cohort study.
003210 (2001) Ali H. Rajput [Canada]Levodopa prolongs life expectancy and is non-toxic to substantia nigra
003555 (2000) S. L. Mitchell [États-Unis] ; K. Rockwood [Canada]The association between parkinsonism, Alzheimer's disease, and mortality: A comprehensive approach
004549 (1992) James W. Schulzer [Canada] ; E. Mak [Canada] ; D. B. Calne [Canada]The antiparkinson efficacy of deprenyl derives from transient improvement that is likely to be symptomatic
005614 (????) C. Schwab [Canada] ; M. Schulzer ; J C Steele ; P L McgeerOn the survival time of a tangled neuron in the hippocampal CA4 region in parkinsonism dementia complex of Guam.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Survival Analysis" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Survival Analysis" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Survival Analysis
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022